Kaleorid (Potassium Chloride)

Potassium chloride dissociates after ingestion, releasing potassium ions that are absorbed through the gastrointestinal tract into the bloodstream. The increased extracellular potassium raises serum potassium concentrations, re‑establishing the electrochemical gradient needed for cellular excitability, nerve impulse transmission, and proper cardiac muscle contraction.

The appropriate dose of Kaleorid is determined by a qualified prescriber based on the patient’s serum potassium level, renal function, and overall clinical condition. Dosing is individualized, and the prescriber will specify the exact amount and frequency needed to safely correct the potassium deficit.

Limited clinical data are available for potassium chloride use in pregnancy and lactation. It should only be used when the potential benefit justifies any possible risk to the fetus or infant. Healthcare providers will evaluate the mother’s potassium status and consider alternative therapies if appropriate.

To order Kaleorid, submit an enquiry on the product page at gnhindia.com, providing the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials. The sales team will then respond with pricing, availability, shipping details and any necessary import documentation.

Kaleorid delivers potassium as potassium chloride, which provides a high elemental potassium content per dose and is rapidly absorbed. Alternative oral potassium salts, such as potassium gluconate or potassium citrate, contain lower elemental potassium and may be chosen for specific gastrointestinal tolerability or acid‑base considerations. The choice depends on clinical needs and physician preference.

Kaleorid should be stored at ambient temperature, below 25 °C, in its original container. Protect the product from moisture, direct sunlight, and extreme temperatures. Keep the packaging tightly closed and out of reach of children to maintain potency and safety.

Kaleorid is taken orally, usually with a full glass of water. It can be swallowed whole or, if the formulation permits, dissolved in a small amount of liquid before ingestion. The prescriber will advise whether it should be taken with food or on an empty stomach based on individual tolerance.

The most serious risks involve excessive potassium accumulation, known as hyperkalemia, which can lead to cardiac arrhythmias, muscle weakness, and potentially life‑threatening heart rhythm disturbances. Severe allergic reactions, though rare, may also occur. Patients should be monitored closely for signs of elevated potassium, especially if they have renal impairment or are on interacting medications.

Kaleorid should be avoided in individuals with known hyperkalemia, severe renal failure, or conditions that predispose to dangerous potassium accumulation. It is also contraindicated in patients with a documented hypersensitivity to potassium chloride or any component of the formulation. Clinicians must assess each patient’s medical history before prescribing.